REalloys Reports Third Quarter 2026 Results
REALLOYS INC. (ALOY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE REalloys Reports Third Quarter 2026 Results Executes term sheet with the U.S. Army for a heavy rare earth processing facility at Tooele Army Depot; advances SRC metallization and Rare Earth Processing Facility programs; outlines steps toward tar
How this was made
The 30-second read
Why it matters
The earnings release combines a net loss with significant cash reserves and a new defense contract, creating a mixed outlook for short‑term price action but potential upside in the rare earth supply chain.
Market read
The filing provides fresh earnings data and a strategic defense partnership, relevant for investors in REalloys and the broader rare earth sector.
What to watch
The company's virtually debt‑free balance sheet and $116M cash cushion provide runway for upcoming capital‑intensive projects.
REalloys reports Q3 2026 net loss of $30.5 million, $25.3 million of it non-cash stock compensation, with $116.2 million of cash and a non-binding Army term sheet at Tooele
Revenue is small ($413 thousand in the quarter) and the GAAP net loss is driven mainly by non-cash stock compensation. Cash rose to $116,182 thousand and the company describes the balance sheet as virtually debt-free. Operating cash use was $(23,431) thousand for nine months, and the project milestones depend on a non-binding term sheet and future financing.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net revenues, Q3 2026 (3 months ended Sep 30, 2026)GAAP | $413K | – | – |
| Cost of sales, Q3 2026GAAP | $263K | – | – |
| Gross margin, Q3 2026 (as stated in the release)other | approximately 36% | – | – |
| General and administrative expense (GAAP), Q3 2026GAAP | $30.26M | – | – |
| Adjusted General and Administrative Expense (excludes non-cash stock-based compensation), Q3 2026non-GAAP | $4.94M | – | – |
| Advertising and marketing, Q3 2026GAAP | $486K | – | – |
| Depreciation and amortization, Q3 2026GAAP | $185K | – | – |
| Total operating expenses, Q3 2026GAAP | $31.20M | – | – |
| Loss from operations, Q3 2026GAAP | −$30.78M | – | – |
| Interest expense, Q3 2026GAAP | $7K | – | – |
| Change in fair value of contingent consideration, Q3 2026GAAP | – | – | – |
| Deferred cash consideration late payment penalties, Q3 2026GAAP | – | – | – |
| Other (income) expense, net, Q3 2026GAAP | −$252K | – | – |
| Total other (income) expense, Q3 2026GAAP | −$245K | – | – |
| Net loss, Q3 2026GAAP | −$30.54M | – | – |
| Basic and diluted net loss per share, Q3 2026GAAP | $(0.44) | – | – |
| Net revenues, nine months 2026 (9M Sep 30, 2026)GAAP | $1.92M | – | – |
| Cost of sales, nine months 2026GAAP | $890K | – | – |
| Software development costs, nine months 2026GAAP | $68K | – | – |
| General and administrative expense (GAAP), nine months 2026GAAP | $151.7M | – | – |
| Adjusted General and Administrative Expense (excludes non-cash stock-based compensation), nine months 2026non-GAAP | $12.54M | – | – |
| Advertising and marketing, nine months 2026GAAP | $4.34M | – | – |
| Depreciation and amortization, nine months 2026GAAP | $177K | – | – |
| Total operating expenses, nine months 2026GAAP | $157.2M | – | – |
| Loss from operations, nine months 2026GAAP | −$155.3M | – | – |
| Interest expense, nine months 2026GAAP | $29K | – | – |
| Change in fair value of contingent consideration, nine months 2026GAAP | $3.44M | – | – |
| Deferred cash consideration late payment penalties, nine months 2026GAAP | – | – | – |
| Impairment expense, nine months 2026GAAP | $6.39M | – | – |
| Accretion of discount on issuance of Series C Preferred Stock, nine months 2026GAAP | $9.22M | – | – |
| Other (income) expense, net, nine months 2026GAAP | −$275K | – | – |
| Total other (income) expense, nine months 2026GAAP | $18.81M | – | – |
| Net loss, nine months 2026GAAP | −$174.1M | – | – |
| Basic and diluted net loss per share, nine months 2026GAAP | $(2.83) | – | – |
| Net cash used in operating activities, nine months 2026GAAP | −$23.43M | – | – |
| Cash balance at Sep 30, 2026GAAP | $116.2M | – | – |
| Total assets at Sep 30, 2026GAAP | $197.4M | – | – |
| Total stockholders' equity at Sep 30, 2026GAAP | $177.6M | – | – |
| Working capital at Sep 30, 2026other | $123.4M | – | – |
Capital returns
- The release reports no share repurchases and no dividends for the period.
- Weighted-average shares outstanding, basic and diluted, were 69,050,348 for Q3 2026 against 44,490,419 for Q3 2025.
- Series C Preferred Stock accretion of $9,220 thousand was recorded in the nine months ended Sep 30, 2026.
What drove it
- The company states the net loss was driven primarily by $25.3 million of non-cash stock-based compensation for director, officer and consultant equity awards, primarily granted in connection with the February 2026 transition to a Nasdaq-listed public company.
- For nine months 2026, the company lists $158.2 million of non-cash charges: principally $139.2 million of stock-based compensation, $9.2 million of preferred share accretion, a $6.4 million impairment related to assets acquired through the Blackboxstocks merger and a $3.4 million change in the fair value of settled derivatives.
- The company states that Euclid facility sales drove revenue growth in the quarter, with approximately 36% gross margin.
- The company deployed $16.5 million to SRC programs in the first nine months of 2026: $11.6 million toward the Heavy Rare Earth Metallization Facility, $3.7 million toward the Rare Earth Processing Facility upgrade and $1.2 million toward process development.
- The company states initial SRC upgrade funding covers NdPr metallization units, about one-third of the estimated total upgrade budget.
- The company states the remaining SRC upgrade funds, mainly for the separation system, were deferred to 2027 while near-term SRC activity focuses on commissioning and operating the existing facility.
- The company states the shift in SRC trial timing reflects feedstock alignment and procurement lead times, and that it does not expect the change to affect its broader strategic execution plan.
- On November 3, 2026, the company and the Department of the Army executed a non-binding term sheet for a definitive Enhanced Use Lease on about 200 acres at Tooele Army Depot, Utah.
Concerns
- GAAP net loss was $(30,539) thousand in Q3 2026 and $(174,075) thousand for nine months, with EPS of $(0.44) and $(2.83).
- Net cash used in operating activities was $(23,431) thousand for nine months 2026, against $(2,631) thousand a year earlier.
- The Army term sheet is non-binding, other than certain customary provisions. The release lists conditions including agreement on rent, completion of environmental reviews, project financing and Board approval.
- The company states that the location, timing and capital requirements of the separation, metallization and magnet facilities have not been determined and are expected to require significant additional financing.
- The company states it is evaluating alternative sites because a definitive lease may not accommodate all planned facilities.
- Remaining SRC commitments of approximately $56.0 million run through 2028, against cash of $116,182 thousand at Sep 30, 2026.
- The remaining SRC upgrade funds were deferred to 2027, and the SRC processing and separation trials moved from 2026 into the first half of 2027.
- Revenue is small: net revenues were $413 thousand in Q3 2026 and $1,923 thousand for nine months 2026.
What to watch
- Negotiation of a definitive Enhanced Use Lease at Tooele Army Depot, including rent terms and the conditions listed in the term sheet.
- Access to NdPr metallization capability at SRC, which the company expects to begin in the first quarter of 2027.
- Completion of processing and separation trials at SRC through the first half of 2027.
- Initial separated oxide production from the SRC facility, expected in the second half of 2027, and commercial intake of NdPr metal and dysprosium and terbium oxides, expected to start in the third quarter of 2027.
- Release of the deferred SRC separation system funds in 2027.
- Commissioning of the Heavy Rare Earth Metallization Facility, targeted for the first quarter of 2028, with initial operations in the first half of 2028.
- Financing plans for the planned separation, metallization and magnet platform, which the company states will require significant additional financing.
- Trend in operating cash use and in the non-cash stock-based compensation charges in future periods.
Balance sheet and cash flow
- Cash was $116,182 thousand at Sep 30, 2026, against $2,824 thousand at Dec 31, 2025.
- Total current assets were $129,055 thousand at Sep 30, 2026, against $38,541 thousand at Dec 31, 2025.
- Total assets were $197,373 thousand at Sep 30, 2026, against $93,389 thousand at Dec 31, 2025.
- Total liabilities were $19,740 thousand at Sep 30, 2026, against $56,049 thousand at Dec 31, 2025.
- Total stockholders' equity was $177,633 thousand at Sep 30, 2026, against $35,834 thousand at Dec 31, 2025.
- Accumulated deficit was $(255,200) thousand at Sep 30, 2026, against $(81,125) thousand at Dec 31, 2025.
- Nine months 2026 cash flows: operating $(23,431) thousand (2025: $(2,631) thousand); investing $(8,528) thousand (2025: $(53) thousand); financing $145,317 thousand (2025: $2,844 thousand); net change in cash $113,358 thousand (2025: $160 thousand).
- Remaining commitments under the SRC development agreements were approximately $56.0 million at Sep 30, 2026, expected to be incurred through 2028.
- The company states it expects to fund these requirements, planned R&D spending and general corporate costs from existing cash, without reliance on any specific future financing transaction.
Analysis
REalloys reported third-quarter 2026 net revenues of $413 thousand, against $186 thousand a year earlier, with cost of sales of $263 thousand. The release states approximately 36% gross margin on Euclid facility sales. Operating expenses rose to $31,197 thousand, and the GAAP net loss was $(30,539) thousand, or $(0.44) per diluted share, compared with $(25,588) thousand, or $(0.58), in the prior-year quarter. The company attributes the loss mainly to $25.3 million of non-cash stock-based compensation. Excluding that item, the company's non-GAAP Adjusted General and Administrative Expense was $4,944 thousand in the quarter, a figure the release does not give for the prior-year quarter.
For the nine months, net revenues were $1,923 thousand against $626 thousand, and the net loss was $(174,075) thousand, or $(2.83) per share, against $(29,531) thousand, or $(0.75). The nine-month loss includes $139.2 million of stock-based compensation, $9.2 million of Series C preferred accretion, a $6.4 million impairment and a $3.4 million change in fair value of settled derivatives, as listed by the company. Operating cash use was $(23,431) thousand, against $(2,631) thousand a year earlier, and investing use was $(8,528) thousand. Financing brought in $145,317 thousand, so cash rose to $116,182 thousand at September 30, 2026, from $2,824 thousand at December 31, 2025. Total assets were $197,373 thousand and stockholders' equity $177,633 thousand.
The release is mainly a strategic update. Its most concrete development is a non-binding term sheet with the Department of the Army, executed on November 3, 2026, for a definitive Enhanced Use Lease at Tooele Army Depot. The release also describes initial funding of about one-third of the SRC upgrade budget, to give NdPr metallization access from the first quarter of 2027. It also says the remaining SRC funds were deferred to 2027 and that SRC trials moved into the first half of 2027. The company states that the trial timing shift reflects feedstock alignment and procurement lead times. Remaining SRC commitments are about $56.0 million through 2028.
The release gives no numeric financial guidance. Its forward statements are milestones: Heavy Rare Earth Metallization Facility commissioning in the first quarter of 2028, initial U.S. magnet production of about 3,000 tonnes per year no later than 2030 (described as design targets, not commitments), and about $10 million of R&D, piloting and product qualification spending through 2027. The company states it expects to fund committed programs from existing cash, while also stating that the larger facilities will require significant additional financing. The figures to watch are the cash balance against the $56.0 million of SRC commitments, the operating cash burn, and whether the milestones hold.
Management, verbatim
This quarter we moved further from planning into execution.
Leonard Sternheim, Chief Executive Officer of REalloys
Not in the filing
stated, not guessed- Prior-year and prior-quarter gross margin for Q3 2026 and nine months 2026 are not printed.
- Year-over-year percentage changes for revenue, expenses and losses are not printed in the release and were not calculated.
- Prior-quarter (Q2 2026) results are not provided, so sequential changes are null.
- Prior-year quarter Adjusted General and Administrative Expense is not printed.
- Free cash flow is not printed; only operating, investing and financing cash flows are reported.
- Segment or product-line revenue breakdown is not reported.
- Numeric financial guidance for revenue, margins, expenses or tax rate is not provided; only project milestones and targets are given.
- Balance sheet comparisons are against December 31, 2025, not the prior-year quarter, so they are kept in balance_sheet_cash_flow rather than as prior-year figures.
- Stock price reaction and analyst consensus are not provided in the filing.
- The previous outlook contained only project timing and capacity statements with no numeric guidance for the third quarter of 2026 that matches a reported metric.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
REalloys (Nasdaq: ALOY) filed an 8‑K reporting its third quarter 2026 financials and strategic updates, including a non‑binding term sheet with the U.S. Army for a heavy rare earth processing facility at Tooele Army Depot.
Ticker impact
REalloys reported Q3 2026 results with $0.4M revenue and a $30.5M net loss, plus a term sheet with the U.S. Army for a heavy rare earth processing facility.
likely downward pressure as investors digest the loss despite cash strength and contract news
Losses driven by large stock‑based compensation outweigh the positive contract news; market may penalize earnings while noting future upside from the Army term sheet.
Market effects
Highlights growing U.S. focus on domestic rare earth supply, potentially benefiting the broader rare earth sector.
U.S. defense and industrial customers may see increased sourcing from domestic producers.
Limited to investors tracking rare earth and defense supply chain developments.
Counterpoint
The Army term sheet could be a catalyst for a longer‑term rally if execution proceeds on schedule.
Key entities
- GovernmentU.S. Army
Entered a non‑binding term sheet with REalloys for a heavy rare earth processing facility.
- PartnerSRC
Provides NdPr metallization capacity; REalloys funded upgrades in 2026.



